Recent advances in diagnosis and treatment of transitional cell carcinoma of the bladder

Clarissa Martyn-Hemphill; Davina Mak; Mohammed Shamim Khan; Benjamin Challacombe; Conrad V. Bishop

doi:10.1016/j.ijsu.2013.08.018

Recent advances in diagnosis and treatment of transitional cell carcinoma of the bladder

Clarissa Martyn-Hemphill, Davina Mak, Mohammed Shamim Khan, Benjamin Challacombe, Conrad V. Bishop^*

^*Corresponding author for this work

GSTT Guy's and St Thomas' NHS Foundation Trust

Research output: Contribution to journal › Literature review › peer-review

15 Citations (Scopus)

Abstract

The management of transitional cell carcinoma of the bladder (TCCB) presents a challenge to urological surgeons due to the diversity of patient factors, stage at presentation and propensity for disease recurrence and progression. Advances in the last decade have seen an evolution in techniques for diagnosis, treatment and ongoing surveillance. A good understanding of our patients, the disease and the available diagnostic and therapeutic options is essential for the management of this condition. We review the current literature focusing on the merits of recent advances in this field. Given the breadth of the subject, we have deliberately selected only the most relevant and recent advances already in clinical use.

Original language	English
Pages (from-to)	749-752
Number of pages	4
Journal	International Journal Of Surgery
Volume	11
Issue number	9
DOIs	https://doi.org/10.1016/j.ijsu.2013.08.018
Publication status	Published - Nov 2013

Keywords

Transitional cell carcinoma
Bladder cancer
Diagnosis
Treatment
Advances
ASSISTED RADICAL CYSTECTOMY
IN-SITU HYBRIDIZATION
RANDOMIZED CONTROLLED-TRIAL
CALMETTE-GUERIN THERAPY
FLUORESCENCE CYSTOSCOPY
TRANSURETHRAL RESECTION
PHOTODYNAMIC DIAGNOSIS
URINARY-DIVERSION
ELECTROMOTIVE MITOMYCIN
UROTHELIAL CARCINOMA

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.1016/j.ijsu.2013.08.018

Cite this

@article{95124dc633c6476691bc36485fb6230e,

title = "Recent advances in diagnosis and treatment of transitional cell carcinoma of the bladder",

abstract = "The management of transitional cell carcinoma of the bladder (TCCB) presents a challenge to urological surgeons due to the diversity of patient factors, stage at presentation and propensity for disease recurrence and progression. Advances in the last decade have seen an evolution in techniques for diagnosis, treatment and ongoing surveillance. A good understanding of our patients, the disease and the available diagnostic and therapeutic options is essential for the management of this condition. We review the current literature focusing on the merits of recent advances in this field. Given the breadth of the subject, we have deliberately selected only the most relevant and recent advances already in clinical use.",

keywords = "Transitional cell carcinoma, Bladder cancer, Diagnosis, Treatment, Advances, ASSISTED RADICAL CYSTECTOMY, IN-SITU HYBRIDIZATION, RANDOMIZED CONTROLLED-TRIAL, CALMETTE-GUERIN THERAPY, FLUORESCENCE CYSTOSCOPY, TRANSURETHRAL RESECTION, PHOTODYNAMIC DIAGNOSIS, URINARY-DIVERSION, ELECTROMOTIVE MITOMYCIN, UROTHELIAL CARCINOMA",

author = "Clarissa Martyn-Hemphill and Davina Mak and Khan, {Mohammed Shamim} and Benjamin Challacombe and Bishop, {Conrad V.}",

year = "2013",

month = nov,

doi = "10.1016/j.ijsu.2013.08.018",

language = "English",

volume = "11",

pages = "749--752",

journal = "International Journal Of Surgery",

issn = "1743-9191",

publisher = "Elsevier",

number = "9",

}

TY - JOUR

T1 - Recent advances in diagnosis and treatment of transitional cell carcinoma of the bladder

AU - Martyn-Hemphill, Clarissa

AU - Mak, Davina

AU - Khan, Mohammed Shamim

AU - Challacombe, Benjamin

AU - Bishop, Conrad V.

PY - 2013/11

Y1 - 2013/11

N2 - The management of transitional cell carcinoma of the bladder (TCCB) presents a challenge to urological surgeons due to the diversity of patient factors, stage at presentation and propensity for disease recurrence and progression. Advances in the last decade have seen an evolution in techniques for diagnosis, treatment and ongoing surveillance. A good understanding of our patients, the disease and the available diagnostic and therapeutic options is essential for the management of this condition. We review the current literature focusing on the merits of recent advances in this field. Given the breadth of the subject, we have deliberately selected only the most relevant and recent advances already in clinical use.

AB - The management of transitional cell carcinoma of the bladder (TCCB) presents a challenge to urological surgeons due to the diversity of patient factors, stage at presentation and propensity for disease recurrence and progression. Advances in the last decade have seen an evolution in techniques for diagnosis, treatment and ongoing surveillance. A good understanding of our patients, the disease and the available diagnostic and therapeutic options is essential for the management of this condition. We review the current literature focusing on the merits of recent advances in this field. Given the breadth of the subject, we have deliberately selected only the most relevant and recent advances already in clinical use.

KW - Transitional cell carcinoma

KW - Bladder cancer

KW - Diagnosis

KW - Treatment

KW - Advances

KW - ASSISTED RADICAL CYSTECTOMY

KW - IN-SITU HYBRIDIZATION

KW - RANDOMIZED CONTROLLED-TRIAL

KW - CALMETTE-GUERIN THERAPY

KW - FLUORESCENCE CYSTOSCOPY

KW - TRANSURETHRAL RESECTION

KW - PHOTODYNAMIC DIAGNOSIS

KW - URINARY-DIVERSION

KW - ELECTROMOTIVE MITOMYCIN

KW - UROTHELIAL CARCINOMA

U2 - 10.1016/j.ijsu.2013.08.018

DO - 10.1016/j.ijsu.2013.08.018

M3 - Literature review

SN - 1743-9191

VL - 11

SP - 749

EP - 752

JO - International Journal Of Surgery

JF - International Journal Of Surgery

IS - 9

ER -

Recent advances in diagnosis and treatment of transitional cell carcinoma of the bladder

Abstract

Keywords

UN SDGs

Access to Document

Fingerprint

Cite this